The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hancock Richard B since 2019.
This trader's CIK number is 1723288.
At the time of last reporting, Hancock Richard B was the Officer of Avid Bioservices, Inc.. (stock ticker symbol CDMO).
Also see all insider trading activities at Avid Bioservices, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CDMO | 38,803 | $202,047 | 0 | $0 | 26,756 | $0 |
| 2023 | CDMO | 23,000 | $134,734 | 30,000 | $505,845 | 44,247 | $105,510 |
| 2022 | CDMO | 0 | $0 | 58,321 | $1,085,887 | 60,002 | $220,156 |
| 2021 | CDMO | 0 | $0 | 10,000 | $320,415 | 19,392 | $22,708 |
| 2020 | CDMO | 12,500 | $49,875 | 0 | $0 | 4,987 | $0 |
| 2019 | CDMO | 10,000 | $50,910 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-14 | CDMO | Option Ex | 26,756 | .00 | 0 |
| 2023-12-13 | CDMO | Buy | 38,803 | 5.21 | 202,047 |
| 2023-12-15 | CDMO | Buy | 23,000 | 5.86 | 134,734 |
| 2023-12-14 | CDMO | Option Ex | 9,612 | .00 | 0 |
| 2023-07-10 | CDMO | Option Ex | 7,014 | .00 | 0 |
| 2023-06-06 | CDMO | Option Ex | 12 | 4.53 | 54 |
| 2023-06-06 | CDMO | Sale | 5,000 | 16.18 | 80,920 |
| 2023-05-07 | CDMO | Option Ex | 4,988 | .00 | 0 |
| 2023-05-01 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2023-05-01 | CDMO | Sale | 5,000 | 17.92 | 89,600 |
| 2023-04-03 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2023-04-03 | CDMO | Sale | 5,000 | 18.46 | 92,280 |
| 2023-03-01 | CDMO | Sale | 5,000 | 16.59 | 82,970 |
| 2023-03-01 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2023-02-01 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2023-02-01 | CDMO | Sale | 5,000 | 16.02 | 80,075 |
| 2023-01-12 | CDMO | Sale | 5,000 | 16.00 | 80,000 |
| 2023-01-12 | CDMO | Option Ex | 2,621 | 4.60 | 12,056 |
| 2022-12-02 | CDMO | Sale | 10,000 | 16.11 | 161,119 |
| 2022-12-02 | CDMO | Option Ex | 10,000 | 4.53 | 45,300 |
| 2022-10-03 | CDMO | Option Ex | 5,000 | 4.60 | 23,000 |
| 2022-10-03 | CDMO | Sale | 5,000 | 18.65 | 93,265 |
| 2022-09-01 | CDMO | Option Ex | 2,987 | 4.53 | 13,531 |
| 2022-09-01 | CDMO | Sale | 3,321 | 17.10 | 56,775 |
| 2022-08-01 | CDMO | Sale | 5,000 | 19.40 | 96,980 |
| 2022-07-10 | CDMO | Option Ex | 7,014 | .00 | 0 |
| 2022-07-05 | CDMO | Option Ex | 5,000 | 4.53 | 22,650 |
| 2022-07-05 | CDMO | Sale | 5,000 | 16.03 | 80,155 |
| 2022-06-24 | CDMO | Option Ex | 1,211 | 4.60 | 5,570 |
| 2022-06-24 | CDMO | Sale | 2,463 | 16.01 | 39,440 |
| 2022-06-27 | CDMO | Option Ex | 3,802 | 4.67 | 17,755 |
| 2022-06-27 | CDMO | Sale | 7,537 | 16.07 | 121,089 |
| 2022-05-07 | CDMO | Option Ex | 4,988 | .00 | 0 |
| 2022-04-01 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2022-04-01 | CDMO | Sale | 5,000 | 21.21 | 106,065 |
| 2022-03-01 | CDMO | Option Ex | 5,000 | 4.67 | 23,350 |
| 2022-03-01 | CDMO | Sale | 5,000 | 19.86 | 99,309 |
| 2022-02-01 | CDMO | Sale | 5,000 | 18.81 | 94,045 |
| 2022-02-01 | CDMO | Option Ex | 5,000 | 4.60 | 23,000 |
| 2022-01-03 | CDMO | Option Ex | 5,000 | 4.53 | 22,650 |
| 2022-01-03 | CDMO | Sale | 5,000 | 27.53 | 137,645 |
| 2021-12-14 | CDMO | Option Ex | 2,379 | .00 | 0 |
| 2021-12-01 | CDMO | Option Ex | 5,000 | 4.53 | 22,650 |
| 2021-12-01 | CDMO | Sale | 5,000 | 30.90 | 154,510 |
| 2021-11-15 | CDMO | Sale | 5,000 | 33.18 | 165,905 |
| 2021-11-15 | CDMO | Option Ex | 13 | 4.53 | 58 |
| 2021-07-10 | CDMO | Option Ex | 7,013 | .00 | 0 |
| 2021-05-07 | CDMO | Option Ex | 4,987 | .00 | 0 |
| 2020-05-07 | CDMO | Option Ex | 4,987 | .00 | 0 |
| 2020-03-13 | CDMO | Buy | 12,500 | 3.99 | 49,875 |
| 2019-09-10 | CDMO | Buy | 10,000 | 5.09 | 50,910 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hancock Richard B (Officer of Avid Bioservices, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.